Lcl-161
| CAS No. | 1005342-46-0 |
|---|---|
| MDL No. | MFCD23160049 |
| MF | C26H33FN4O3S |
| MW | 500.60 |
| InChI Key | UFPFGVNKHCLJJO-SSKFGXFMSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
LCL161 is a small molecule IAP inhibitor with potent antitumour activity in solid tumours. In HCC, its therapeutic response is mediated by Bcl-2 expression. It functions as an antineoplastic agent and apoptosis inducer. Chemically, it is an aromatic ketone, a monofluorobenzene, a N-acylpyrrolidine, a 1,3-thiazole, and a L-alanine derivative.
| CAS No. | 1005342-46-0 |
|---|---|
| Product Name | Lcl-161 |
Associated Conditions
polycythemia vera·breast cancer·neoplasm·pancreatic carcinoma·primary myelofibrosis·
* The information provided here is compiled from public sources and is for reference only.